Clinical Trials

Search for trials
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1
  • Intervention Type: Drug
  • Participants: 20
  • Start Date: September 30, 2020
A Phase 1b, Open-Label Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma With Excess Glucocorticoid Production
Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Other, Behavioral
  • Participants: 120
  • Start Date: September 1, 2020
Effects of Mindfulness Therapy in Patients With Acromegaly and in Patients With Cushing's Syndrome
Search for trials
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Diagnostic Test
  • Participants: 60
  • Start Date: July 2020
Usefulness of Hair Cortisol/Cortisone Concentrations for the Monitoring of Medical Treatment in Patients With Cushing's Disease
Clinical Trial
  • Status: Not yet recruiting
  • Participants: 200
  • Start Date: June 15, 2020
Skin Microcirculation Evaluation With Nailfold Capillaroscopy in Cushing's Syndrome Patients
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 3
  • Intervention Type: Drug, Other
  • Participants: 130
  • Start Date: May 19, 2020
Glucocorticoid Receptor Antagonism in the Treatment of Hypercortisolism in Patients With Cortisol-Secreting Adrenal Adenomas or Hyperplasia: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Relacorilant
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Other
  • Participants: 100
  • Start Date: July 25, 2019
Predictors and Effect of Biofeedback Intervention on the Severity of Glucocorticoid Withdrawal Syndrome After Curative Surgery in Patients With Endogenous Cushing Syndrome
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 3
  • Intervention Type: Drug
  • Participants: 60
  • Start Date: January 7, 2019
An Open-label Extension Study of Levoketoconazole (2S,4R-ketoconazole) in the Treatment of Endogenous Cushing's Syndrome
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Procedure
  • Participants: 68
  • Start Date: January 2, 2019
Impact of Adrenal IncidenTalomas and Possible Autonomous Cortisol Secretion on Cardiovascular and Metabolic Alterations (ITACA Study)
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 3
  • Intervention Type: Other, Drug
  • Participants: 130
  • Start Date: October 16, 2018
Glucocorticoid Receptor Antagonism in the Treatment of Cushing Syndrome (GRACE): A Phase 3, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study of the Efficacy and Safety of Relacorilant
Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Dietary Supplement
  • Participants: 30
  • Start Date: October 16, 2018
Effects of Liquorice on Salivary Cortisol and Cortisone
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 180
  • Start Date: October 5, 2018
An Open-label, Multi-center, Roll-over Study to Assess Long Term Safety in Patients With Endogenous Cushing's Syndrome Who Have Completed a Prior Novartis-sponsored Osilodrostat (LCI699) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Osilodrostat
Clinical Trial
  • Status: Enrolling by invitation
  • Intervention Type: Other
  • Participants: 1500
  • Start Date: October 1, 2018
A Prospective Cohort Study for Patients With Adrenal Diseases
Showing 1-12 of 28